CZ ATC L01EA01 · updated 2 Nov 2026
Imatinib shortage in Czechia
Is there an Imatinib shortage in Czechia?
Yes. As of 2 Nov 2026, 2 Imatinib products are reported short in Czechia, the first since 31 Dec 2025. The company estimate for the return is 1 Jan 2027. Main reason: commercial decision or withdrawal.
Also short in Canada, Italy, Spain, Belgium, Australia. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | IMATINIB GRINDEKS 100MG 100MG CPS DUR 120 | AS GRINDEKS, Riga | 31 Dec 2025 | 1 Jan 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | IMATINIB GRINDEKS 100MG 100MG CPS DUR 60 | AS GRINDEKS, Riga | 31 Dec 2025 | 1 Jan 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.